Explore
Validate
Learn20810-1-AP
antibody from Proteintech Group
Targeting: ALG13
CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20810-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20810-1-AP, RRID:AB_10694830
- Product name
- ALG13 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ALG13 antibody (Cat. #20810-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions.
ALG13 Deficiency Associated with Increased Seizure Susceptibility and Severity.
Dysregulation of the Expression of Asparagine-Linked Glycosylation 13 Short Isoform 2 Affects Nephrin Function by Altering Its N-Linked Glycosylation.
Ng BG, Eklund EA, Shiryaev SA, Dong YY, Abbott MA, Asteggiano C, Bamshad MJ, Barr E, Bernstein JA, Chelakkadan S, Christodoulou J, Chung WK, Ciliberto MA, Cousin J, Gardiner F, Ghosh S, Graf WD, Grunewald S, Hammond K, Hauser NS, Hoganson GE, Houck KM, Kohler JN, Morava E, Larson AA, Liu P, Madathil S, McCormack C, Meeks NJL, Miller R, Monaghan KG, Nickerson DA, Palculict TB, Papazoglu GM, Pletcher BA, Scheffer IE, Schenone AB, Schnur RE, Si Y, Rowe LJ, Serrano Russi AH, Russo RS, Thabet F, Tuite A, Villanueva MM, Wang RY, Webster RI, Wilson D, Zalan A, Undiagnosed Diseases Network, University of Washington Center for Mendelian Genomics (UW-CMG), Wolfe LA, Rosenfeld JA, Rhodes L, Freeze HH
Journal of inherited metabolic disease 2020 Nov;43(6):1333-1348
Journal of inherited metabolic disease 2020 Nov;43(6):1333-1348
ALG13 Deficiency Associated with Increased Seizure Susceptibility and Severity.
Gao P, Wang F, Huo J, Wan D, Zhang J, Niu J, Wu J, Yu B, Sun T
Neuroscience 2019 Jun 15;409:204-221
Neuroscience 2019 Jun 15;409:204-221
Dysregulation of the Expression of Asparagine-Linked Glycosylation 13 Short Isoform 2 Affects Nephrin Function by Altering Its N-Linked Glycosylation.
Esposito T, De Stefano G, Reccia MG, Di Lorenzo I, Napolitano F, Scalabrì F, Lombardi A, Saleem MA, Griffiths LR, Gianfrancesco F
Nephron 2017;136(2):143-150
Nephron 2017;136(2):143-150
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 20810-1-AP(ALG13 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of Hela cells, using ALG13 antibody 20810-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human stomach using 20810-1-AP(ALG13 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human stomach using 20810-1-AP(ALG13 antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue
